These findings are coincident with the result that IL-17A-neutralizing mAb after stroke could reduce the neutrophil infiltration, which led to the recovery of neurological function in MCAO mice (Gelderblom et al., 2012). This evidence concerns the gene IL17A and stroke disorder.